Duma (DUMA) Energy Enters Negotiations for African Concession

HOUSTON, July 11, 2012 (GLOBE NEWSWIRE) — Duma Energy Corp. (OTCBB:DUMA) (the “Company”) is pleased to announce that it has entered into the final stage of negotiations regarding the proposed acquisition by the Company of a private corporation with a significant interest in an African concession totaling approximately 6 million acres (25,000 square km) (the “Proposed Acquisition”). The Company is seeking to expand beyond its current U.S. operations and acquire highly prospective opportunities in emerging exploration regions.

“Our success in the last two years has put us in a strong position for growth. We believe it is the right time to be aggressive and continue to pursue our stated goal of seeking projects that offer huge potential returns. There are great opportunities out there,” said Jeremy G. Driver, President and Chief Executive Officer of Duma Energy Corp.

Any such Proposed Acquisition will be subject to the execution of definitive acquisition documentation together with the satisfaction of certain conditions precedent which would be standard in acquisitions of this type.

About Duma Energy Corp.

Duma Energy Corp. is an aggressive growth company actively producing oil and gas in the continental United States, both on and offshore. Duma Energy will continue increasing revenue, cash flow, and reserves to fund its aggressive growth through acquisition and participation in projects with the potential of providing exponential returns for shareholders. Further information can be found on the Company’s website at www.duma.com.

Forward-looking Statements

This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements, which contain words such as “expect,” “believe” or “plan,” by their nature address matters that are, to different degrees, uncertain. These uncertainties may cause actual future events to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements.

CONTACT: Investor Relations
         Investor Awareness, Inc.
         Tony Schor or James Foy
         847-945-2222
         www.InvestorAwareness.com

Court Refuses to Dismiss GSI Technology’s (GSIT) Antitrust Lawsuit against Cypress Semiconductor

GSI Technology, Inc. (Nasdaq:GSIT) announced today that on Friday, July 6, the United States District Court for the Northern District of California in San Jose issued a decision upholding the sufficiency of the antitrust claims asserted by GSI in its Complaint against Cypress Semiconductor Corporation. The Complaint, filed on July 22, 2011, charges Cypress with conducting an unlawful combination and conspiracy, by and through the QDR Consortium, to exclude GSI and other competitors from the market for high-performance static random access memory (SRAM) devices known as fast synchronous Quad Data Rate (or QDR) SRAMs and Double Data Rate (or DDR) SRAMs.

Cypress had moved to dismiss the Complaint arguing that the claims asserted by GSI failed to state a claim under federal or state antitrust laws. In its decision, the Court rejected virtually all of Cypress’ arguments. The Court held that GSI’s Complaint adequately alleges that the anti-competitive, collusive and conspiratorial conduct of Cypress and certain co-conspirators violates Section 1 of the Sherman Act and also constitutes unlawful restraints of trade and unfair competition under applicable provisions of California law. The Complaint seeks treble damages, in an amount to be determined at trial, a preliminary and permanent injunction prohibiting the continuation of the unfair and illegal business practices and recovery of GSI’s attorneys’ fees and costs. The decision in GSI’s favor will allow GSI to pursue pre-trial discovery on all of the claims alleged.

Lee-Lean Shu, GSI’s President and CEO, noted, “We are, of course, pleased with the Court’s ruling. We are confident that the claims we asserted in the Complaint regarding Cypress’ anticompetitive conduct will be proven at trial and will result in a victory, not only for GSI, but also for the QDR SRAM and DDR SRAM market.”

GSI’s lead trial lawyer in the case, Arthur Shartsis of Shartsis Friese, responded to the decision stating: “The Court’s sweeping decision is an important validation of the public standard setting process in high-tech industries. GSI believes that competitors may not privately conspire to set standards in a way that harms open competition.”

On a related matter, Mr. Shu noted that, “as previously announced, we expect to receive the initial determination of the administrative law judge in the pending International Trade Commission proceeding, also involving Cypress, in late July. We continue to believe that the evidence presented in that proceeding clearly supported our position that GSI has infringed no valid Cypress patents.”

About GSI Technology

Founded in 1995, GSI Technology, Inc. is a leading provider of high performance static random access memory, or SRAM, products primarily incorporated in networking and telecommunications equipment. Headquartered in Sunnyvale, California GSI Technology is ISO 9001 certified and has worldwide factory and sales locations. For more information, please visit www.gsitechnology.com.

Gevo (GEVO) and Beta Renewables Sign Cellulosic Isobutanol Development Agreement

Gevo, Inc. (NASDAQ: GEVO), a leading renewable chemicals and next-generation biofuels company, signed a Joint Development Agreement (JDA) with Beta Renewables, a joint venture between Chemtex and TPG, to develop an integrated process for the production of bio-based isobutanol from cellulosic, non-food biomass.

The project would integrate Beta’s PROESA^TM technology and Gevo’s GIFT^® and ATJ technologies, with anticipated production plants to be located where cellulosic feedstocks such as switchgrass, miscanthus, agriculture residues and other biomass will be readily available. The agreement also anticipates commercialization of the technology upon project success, which could enable renewably sourced, competitively priced jet fuel as well as other chemicals and fuels made from isobutanol.

“Gevo has always said that we are feedstock agnostic and, when the technology and feedstock supply chain are ready, we would use our isobutanol process with cellulosic feedstocks. This allows us to access a larger carbohydrate pool as feedstock for isobutanol production, which help keep costs down and enables production facilities in regions of the world rich in biomass resources,” said Gevo COO and President Chris Ryan in a presentation at the U.S. Department of Energy’s BIOMASS 2012 conference. “With the success of our Luverne, Minn. plant startup and Beta Renewables’ cellulosic sugar technology, we’re ready to position Gevo to be on the forefront of cellulosic isobutanol and isobutanol derivatives, such as jet fuel, through the integration of the companies’ respective technology platforms. Beta Renewables is a leader in cellulosic conversion technology and we look forward to a range of collaborations, including partnering with Beta to meet the requirements of the U.S. government’s Defense Production Act Title III project.”

“This is the latest example of Beta Renewables’ PROESA technology enabling lower-cost delivery of bio products – whether cellulosic ethanol from our first-in-the-world, commercial-scale plant in Crescentino, or from GraalBio’s multiple plants; from jet fuel produced in partnership with Gevo or from other bio-based chemicals. Gevo is a leader in the fermentation of sugar into isobutanol and a great partner for this effort,” said Dario Giordano, Chief Technology Officer of Beta Renewables and M&G Corporate Director.

The companies are evaluating future opportunities to partner on other U.S. and international projects with a long-term goal of developing a licensable package for future interested third parties.

Beta Renewables is currently building a 60,000 metric ton (approximately 20 million gallon) per year bio-refinery in Crescentino, Italy that will produce cellulosic ethanol using its PROESA™ process as well as ‘green’ electricity. Construction has begun and plant startup is targeted for the end of 2012.

About Gevo

Gevo is converting existing ethanol plants into biorefineries to make renewable building block products for the chemical and fuel industries. The Company plans to convert renewable raw materials into isobutanol and renewable hydrocarbons that can be directly integrated on a “drop in” basis into existing chemical and fuel products to deliver environmental and economic benefits. Gevo is committed to a sustainable biobased economy that meets society’s needs for plentiful food and clean air and water. For more information, visit www.gevo.com

About Beta Renewables

Beta Renewables is the leader in making non-food cellulosic biomass practical and cost-competitive for the production of advanced biofuels and biochemicals. Beta Renewables is a unique $350 million (€250M) joint venture formed from the Chemtex division of Gruppo Mossi & Ghisolfi and TPG. The company benefits from over 60 years of success in process development and commercializing hundreds of plants worldwide. Beta Renewables has invested over $200 million (€140M) in the development of the PROESA™ process. The company is currently building the world’s first commercial-scale cellulosic ethanol facility in Crescentino, Italy, expected to start operations by the end of 2012.

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements that are not purely statements of historical fact, and can sometimes be identified by our use of terms such as “intend,” “expect,” “plan,” “estimate,” “future,” “strive” and similar words. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and the company undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although the company believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2011, as amended, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Gevo.

NeoStem (NBS) to Present at the Seventh Annual JMP Securities Healthcare Conference

NEW YORK, July 10, 2012 (GLOBE NEWSWIRE) — NeoStem, Inc. (NYSE MKT:NBS) (“NeoStem” or the “Company”), a cell therapy company, today announced that its CEO will present at the Seventh Annual JMP Securities Healthcare Conference on July 12, 2012.

The presentation will be webcast live and available to view at the following web address: http://wsw.com/webcast/jmp18/nbs/. The webcast will be archived for 90 days following the live presentation.

The Seventh Annual JMP Securities Healthcare Conference

• Date: July 12, 2012, 2:30 PM EDT
• Venue: The Peninsula, New York, NY
• Presenter: Robin L. Smith, M.D., M.B.A., Chairman and CEO of NeoStem

About NeoStem, Inc.

NeoStem, Inc. (“we,” “NeoStem” or the “Company”) continues to develop and build on its core capabilities in cell therapy to capitalize on the paradigm shift that we see occurring in medicine. In particular, we anticipate that cell therapy will have a large role in the fight against chronic disease and in lessening the economic burden that these diseases pose to modern society. Our January 2011 acquisition of Progenitor Cell Therapy, LLC (“PCT”) provides NeoStem with a foundation in both manufacturing and regulatory affairs expertise. We believe this expertise, coupled with our existing research capabilities and collaborations, will allow us to achieve our mission of becoming a premier cell therapy company. Our PCT subsidiary’s manufacturing base is one of the few current Good Manufacturing Practices (“cGMP”) facilities available for contracting in the burgeoning cell therapy industry. Amorcyte, LLC (“Amorcyte”), which we acquired in October 2011, is developing a cell therapy for the treatment of cardiovascular disease. Amorcyte’s lead compound, AMR-001, represents NeoStem’s most clinically advanced therapeutic and Amorcyte is enrolling patients for a Phase 2 trial to investigate AMR-001’s efficacy in preserving heart function after a heart attack. We also expect to begin a Phase 1 clinical trial by 2012/2013 to investigate AMR-001’s utility in arresting the progression of congestive heart failure and the associated comorbidities of that disease. Athelos Corporation (“Athelos”), which is approximately 80%-owned by our subsidiary, PCT, is engaged in collaboration with Becton-Dickinson that is exploring the earlier stage clinical development of a T-cell therapy for autoimmune conditions. In addition, our pre-clinical assets include our VSEL^TM Technology platform as well as our MSC (mesenchymal stem cells) product candidate for regenerative medicine.

For more information on NeoStem, please visit www.neostem.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company’s business strategy, including with respect to the Company’s successful development of cell therapeutics, as well as the future of the cell therapeutics industry. The Company’s actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the “Risk Factors” described in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 20, 2012 and in the Company’s periodic filings with the Securities and Exchange Commission. The Company’s further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.

CONTACT: Trout Group
         Gitanjali Jain Ogawa, Vice President
         Phone: +1-646-378-2949
         Email: gogawa@troutgroup.com

         NeoStem, Inc.
         Robin Smith, CEO
         Phone: +1-212-584-4174
         Email: rsmith@neostem.com

Origin Agritech (SEED) Provides Update on Corn Seed R&D Programs

Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”), a technology-focused supplier of hybrid and genetically modified crop seeds in China, today provided update on its Genetically Modified (“GM”) corn seed pipeline and hybrid corn seed development program.

GM Corn Seed Pipeline

Genetically modified seed products in China must initially undergo a five-stage approval process consisting of Phase 1 – Laboratory Research, Phase 2 – Intermediate Test, Phase 3 – Environment Release Test, Phase 4 – Production Test, leading to the receipt of the Bio-Safety Certificate from Ministry of Agriculture (“MOA”) in Phase 5. Currently, only domestic seed producers such as Origin Agritech are allowed to proceed through all five phases, while international companies are restricted to Phase 1 only and forbidden to proceed to Phases 2 through Phase 5.

Origin’s genetically modified phytase corn was the first GM corn seed which passed all five phases of the GM approval process and received notification of Bio-Safety Certificate. Origin has further incorporated phytase traits into two of its best-selling commercial corn hybrids. Commercialization of these two corn hybrids is pending approval from the Chinese government. Two additional corn hybrids with GM phytase traits are undergoing variety production test.

Phytase is an essential element for the growth and development of all animals by increasing phosphorous absorption. Phytase transgenic corn inputs the phytase trait directly into corn, thus reducing costs for animal feed producers by eliminating the need to mix phytase and corn ingredients together. Origin’s GM phytase-producing corn is expected to reduce the need for inorganic phosphate supplements as animals will directly absorb more phosphate from their feed, reducing animal feed’s high cost.

In addition to GM phytase corn, the Company has been conducting research on other GM traits including herbicide tolerance, insect resistance, nitrogen efficiency, and drought stress tolerance traits in crop seeds.

Along with this press release, a supplementary slide showing Origin’s GM corn seed pipeline has been filed with the Securities and Exchange Commission (“SEC”).

The following is a summary of key developments for Origin’s GM corn seeds since 2011:

• Phytase: Two commercial hybrids with phytase traits have completed the variety production test and are pending the variety approval from the Chinese government. Two additional hybrid varieties with phytase traits are currently under variety production test;
• Glyphosate Tolerance: One GM glyphosate tolerance event (the unique DNA recombination event that took place in one plant cell) passed Phase 3 – Environment Release Test in 2011 and has received MOA’s approval to begin Phase 4 – Production Test. Two more glyphosate tolerance events are being submitted for Phase 3 – Environment Release Test. In addition, more than one thousand events are undergoing Phase 1 – Laboratory Research;
• Bacillus Thuringiensis (Bt): Two insect tolerant events are going through Phase 2 – Intermediate Test. Over two hundred events are undergoing Phase 1 – Laboratory Research;
• Glyphosate + Bacillus Thuringiensis (Bt): As a result of recent successes in Phase 1 – Laboratory Research, six events of the Company’s glyphosate and insect tolerant traits have advanced into Phase 2 – Intermediate Test. More than 4,500 events of the stacked traits (inserting more than one gene in a seed via biotechnology) are being screened in Phase 1 – Laboratory Research.

Hybrid Corn Seed Development Program

In addition to GM crop seeds, Origin has a large R&D program developing conventional hybrid crop seeds. In China, new hybrid seed variety needs to go through an official approval process prior to sales. This approval process typically involves three to four years of registration trials and normally proceeds according to the following sequential steps:

Pre-Registration –> Registration Trial 1 –> Registration Trial 2 –> Field Demo –> Approval

Each step leading up to Approval takes approximately one year unless it needs to be repeated. In some localities Registration Trial 2 and Field Demo are treated as one and the same step.

Along with this press release, a supplementary slide showing Origin’s progress in hybrid corn registration trials and approval from 2009 to 2012 has been filed with the SEC.

In 2012, a total of 64 hybrids were under various stages of registration process: among the 64 hybrids, 33 are at Pre-Registration stage; 18 at Registration Trial 1 stage; 5 at Registration Trial 2 stage; 5 at Field Demo stage; and 3 at Registration Trial 2 + Field Demo stage. As the result of multi-year trials, 3 corn hybrids have been approved in 2012.

Dr. Gengchen Han, Chairman and Chief Executive Officer of Origin Agritech, commented, “During recent years, we have established a leading plant genetic technology platform resulting in one of China’s largest portfolios in GM corn seeds. We are well positioned to capitalize on the advent of genetically modified seed opportunities in China. In addition to our proven GM technology and robust pipeline, our solid operational foundation with wide-reaching sales and technical support, growing in-house germplasm library, and advanced processing and production would help us compete effectively in the market. Our goal is to continue utilizing modern biotechnology to create high-quality GM and hybrid seed products and provide result-oriented solutions to farmers.”

About Origin

Founded in 1997 and headquartered in Zhong-Guan-Cun (ZGC) Life Science Park in Beijing, Origin Agritech Limited (NASDAQ GS: SEED) is China’s leading agricultural biotechnology company, specializing in crop seed breeding and genetic improvement, seed production, processing, distribution, and related technical services. Leading the development of Genetically Modified (GM) technology, Origin Agritech’s phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China’s Ministry of Agriculture. Over the years, Origin has established a robust GM seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits. Staffed by approximately 800 employees, Origin operates 13 marketing centers, 8 production and processing centers and 9 breeding stations nationwide with sales centers located in key crop-planting regions. The Company also operates one winter nursery in Hainan province. Product lines are vertically integrated for corn, rice and canola seeds. For further information, please log on to the Company’s website at: www.originseed.com.cn

Forward Looking Statement

This release contains forward-looking statements. All forward-looking statements included in this release are based on information available to us on the date hereof. These statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results to differ materially from those implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “targets,” “goals,” “projects,” “continue,” or variations of such words, similar expressions, or the negative of these terms or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Neither we nor any other person can assume responsibility for the accuracy and completeness of forward-looking statements. Important factors that may cause actual results to differ from expectations include, but are not limited to, those risk factors discussed in Origin’s filings with the SEC including its annual report on Form 20-F. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

UBPS (UBPSW) to Acquire and Consolidate Three Business Payment Companies

Universal Business Payment Solutions Acquisition Corporation (“UBPS” or the “Company”) (NASDAQ: Common Stock:“UBPS”, Units:“UBPSU”, Warrants:“UBPSW”), a special purpose acquisition company, today announced that it has entered into definitive agreements to acquire three profitable and growing companies to facilitate its strategy of providing end-to-end transaction processing services to small businesses:

• Electronic Merchant Systems (“EMS”), a major credit and debit card sales organization;
• Jet Pay LLC (“JetPay”),atop-15 U. S. credit and debit card processor according to Nilson; and
• A D Computer Corporation (“AD Computer”) and Payroll Tax Filing Services, Inc. (“Payroll Tax Filing”), related payroll processing and tax filing companies.

Mr. Bipin Shah, Chairman and CEO of UBPS, stated, “When we formed UBPS the aim was to follow through on a simple concept ~ small business owners should be able to receive all of their business processing solutions in one place. After a thorough diligence and evaluation process, we feel we have succeeded in offering such solutions with the combination of UBPS and these three profitable and rapidly-growing companies. We believe this ‘all encompassing’ business processing model offers a unique solution not currently available to small business customers. We also worked very diligently at creating a structure that was both internally friendly for these three companies while also providing current and potential investors a valuation greater than that available through investment in other publicly-traded companies in the market.”

Details of Transaction

UBPS will acquire the three companies in a transaction valued at approximately $179 million, of which $104 million will be paid in cash, $38 million in newly issued UBPS common stock, and the balance as future payments in cash and UBPS stock (with $25 million of such future payments contingent on the achievement of certain targets). The cash portion of the consideration will be funded by a combination of a $60 million credit facility and UBPS cash held in trust.

The business combination is subject to approval by the Company’s stockholders, as well as regulatory approval and other customary closing conditions. Assuming these conditions are met, the business combination is expected to close early in the fourth quarter of this year.

Financial Results

On a pro-forma basis for calendar year ended December 31, 2011, the combined entities generated over $70 million in revenues and $17 million in EBITDA, without giving effect to immediately identifiable synergies which UBPS estimates to be in excess of $3.5 million. UBPS expects on a pro-forma basis that the combined company will have $78.9 million in revenue and $20.8 million EBITDA in CY 2012 based solely on the benefits of scale and current organic growth.

Compelling Transaction Valuation Compared to Public Peers

• 8.3x 2012E EBITDA and 6.1x 2013E EBITDA versus publicly-traded peers of 9.9x and 8.9x*
• 12.7x 2012E net income and 8.2x 2013E net income versus peers of 22.1x and 17.9x*

* Based upon UBPS price per common share of $6.08 (current total in trust) \ All data as of June 25, 2012 – Source Capital IQ

Background on Acquisition Businesses

• EMS – Since 1987, EMS has grown to become a leading provider of merchant processing services and electronic transactions. Based in Cleveland, Ohio, the company operates in over 100 U.S. cities serving over 16,000 customers across the country. EMS provides high-quality payment processing services and support to traditional retail merchants. EMS processes and safeguards many types of electronic payment transactions including all major credit cards, debit cards, EBT, stored-value, and electronic check services.
• JetPay is a front and back-end credit and debit card and check processor located in Carrollton, TX, offering a wide array of business processing services and features, combining real-time credit and debit card processing, online payment capabilities, and merchant account services into one solution. With more than two decades of experience, JetPay is a Top 15 payment processing company in volume in the U.S. according to Nilson. The company offers processing services to banks, sales organizations, merchants, and for a number of large e-commerce sites on the web today.
• Since 1971, AD Computer and its related company, Payroll Tax Filing are headquartered near Allentown, PA and have provided comprehensive payroll and payroll tax filing services to businesses of all types and sizes throughout the United States. AD Computer’s payroll system is designed with optimum flexibility to accommodate payrolls of all sizes – from small family businesses to large corporations with up to 10,000 employees. The company has historically focused on local markets in the Lehigh Valley, Pennsylvania region, but has created an adaptable payroll processing infrastructure with capacity to expand into other markets under UBPS.

Innovative Combination to Fill Growing Industry Need

The Company feels that its addressable market is primarily U.S. small business, which according to the US Economic Census currently comprises approximately 30% of the Country’s GDP ($4 trillion) and almost half of the national workforce. Currently, the small business owner primarily requires five distinct payment transaction services: payroll processing and related employee services; debit and credit card processing / accounts receivable processing and billing; accounts payable and procurement; funding related to debit and credit card processing receipts; and stored value card products (PayCards, gift cards, others) for employees. The industry has undergone a period of consolidation, with several companies seeking the necessary scale to compete.

Mr. Shah continued, “The market for payroll processing, card processing and funding is still relatively fragmented, with the majority of small businesses utilizing separate resources for each. We feel that by combining these three companies, we can address this market by providing a complete turnkey business processing solution for customers and do it efficiently. For example, whereas a restaurant may have previously gone to separate companies to get its employee a debit card, process their payroll, and access daily working capital; they can now receive all of those services from UBPS as a one-stop shop. These three companies have a strong and successful history, largely created by the talent of their employees and management. We are looking forward to maximizing the scale of the combined entity, and believe that we have truly created a platform to begin providing a processing structure that is currently not available on the market.”

Upon closing, UBPS expects to serve more than 23,000 small business customers through approximately 400 employees, with significant capacity for expansion. In addition to a strong recurring revenue stream, the combination creates a platform company with the scale to support considerably more small business customers. UBPS believes that while it will be cautious to ensure that the three companies are merged with the least disruption to its customers and employees, management expects that the integration should be completed within 12 months. The Company’s corporate headquarters will continue to be based in Chester County, Pennsylvania.

Industry Leading Management

The UBPS management team will be led by Bipin C. Shah, a renowned innovator in the payments processing industry and referred to as the “founder of debit.” Mr. Shah, who will remain Chairman and CEO of the combined company, was instrumental in developing and expanding the first branded multi-bank ATM Network, known as “MAC” for Money Access Card and Money Access Centers. While serving as Vice Chairman and Chief Operating Officer at CoreStates Financial Corporation, and a Board Member of Visa International, Mr. Shah created the first point-of-sale debit card, an electronic universal debit and credit authorization and capture system, “pay-at-the-pump,” and “cash back” at point-of-sale (POS).

The Company will retain senior members of management of the three platform companies after the close of the transaction:

• Dan Neistadt, President of EMS, and formerly EVP at KeyBank and on MasterCard’s Debit Access Committees and former President of the ETA.
• Trent Voigt, President of JetPay, former EVP of Vectrix, and director at National Business Systems.
• Nick Antich, President of A D Computer, the company he founded in 1971.

The UBPS management team is rounded out by Peter Davidson, CAO, formerly EVP of Genpass, and earlier senior management positions with CoreStates Financial, HSBC and Speer & Associates. UPBS’s management team has a strong track record of achieving returns for its investors and shareholders: combined, Gensar, Genpass and MAC/POS returned an average IRR of 62%.

Concluding Comments From Member of the UBPS Board

Arthur F. Ryan, current UBPS board member and former CEO, Prudential Financial Inc., President and COO of Chase Manhattan Bank, and member of the Board of Visa International, stated, “When I joined the Board of UBPS, our entire goal was to seek and find a solution to the growing needs of the small business owner. I think that Bipin and his team have created a thorough and detailed strategy to leverage three companies as a platform to meet all payment-related needs of these businesses. Having worked with Bipin closely for over 25 years, I feel there is no industry peer that has the experience and results in bringing new products to market, driving down transaction processing costs, and in generating additional processing volume via organic growth and acquisitions. We are enthusiastic to begin integrating these companies and creating a bundled service for our current customer base and large potential market of small business owners.”

Additional Investor Information

UBPS intends to file an investor presentation on Form 8-K with the U.S. Securities and Exchange Commission (SEC) in conjunction with this press release.

The Company will also mail a definitive proxy statement and other relevant documents to its stockholders. UBPS management encourages all current and potential investors and other interested persons to read, when available, the preliminary proxy statement, and amendments thereto, and definitive proxy statement in connection with the Company’s solicitation of proxies for the special meeting to be held to approve the business combination because these proxy statements will contain important information about the Company and the proposed business combination. The definitive proxy statement will be mailed to stockholders of the Company as of the record date to be established for voting on the business combination. Stockholders will also be able to obtain a copy of the preliminary and definitive proxy statement, without charge, once available, at the SEC’s Internet site at http://www.sec.gov.

About UBPS

Universal Business Payment Solutions Acquisition Corporation is a blank check company formed for the purpose of acquiring one or more operating businesses in the payments and payroll processing industries as a platform for further roll-up acquisition opportunities. The Company raised net proceeds of approximately $72 million through its initial public offering in May 2011 led by EarlyBirdCapital, Inc. Please visit www.ubpsac.com for more information.

Participants in the Business Combination

The Company and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of the Company in connection with the proposed business combination. Information regarding the officers and directors of the Company is available in the Company’s annual report on Form 10-K for the year ended December 31, 2011, which has been filed with the SEC. Additional information regarding the interests of such potential participants will be included in the definitive proxy statement/prospectus for the proposed business combination and the other relevant documents filed with the SEC.

Note Regarding Financial Information

Certain financial information and data of EMS, JetPay, and AD Computer contained in this press release is derived from unaudited financial statements and data and may not conform to Regulation S-X. Accordingly, such information and data may be adjusted and presented differently in the proxy materials to be mailed to the Company’s security holders.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. UBPS’s actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, UBPS’s expectations with respect to future performance and anticipated financial impacts of the proposed transaction, the satisfaction of the closing conditions to the proposed transaction, and the timing of the completion of the proposed transaction. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside UBPS’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to, those described under the heading “Risk Factors” in UBPS’s final prospectus, dated May 9, 2011. Other factors include the possibility that the transactions contemplated by a potential transaction agreement do not close, including due to the failure of certain closing conditions.

UBPS cautions that the foregoing list of factors is not exclusive. Additional information concerning these and other risk factors is contained in UBPS’s most recent filings with the Securities and Exchange Commission. All subsequent written and oral forward-looking statements concerning UBPS, a potential transaction agreement, the related transactions, or other matters and attributable to UBPS or any person acting on its behalf, are expressly qualified in their entirety by the cautionary statements above. UBPS cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. UBPS does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

Central European Distribution Corp. (CEDC) and Russian Standard Sign Amended Definitive Agreements

– Russian Standard Confirms its Commitment to Strategic Alliance with CEDC – Reconfirms Its Commitment to Purchase Up to $210M of Newly Issued CEDC Senior Notes – Proceeds To Extinguish CEDC 2013 Notes – CEDC Announces Management Changes, Board Addition

Brightstar and iGo, Inc. (IGOI) Announce Global Distribution Agreement

SCOTTSDALE, Ariz., July 9, 2012 (GLOBE NEWSWIRE) — iGo, Inc. (Nasdaq:IGOI) announced today a global distribution agreement with Brightstar Corp., the world’s largest specialized wireless distributor, whereby Brightstar will distribute a line of mobile accessories under iGo’s Adapt Mobile brand.

The first products under the global distribution agreement will ship to Brightstar during the third quarter of 2012.

“Brightstar is the perfect partner to help us increase sales globally into Carrier, Retailer, and Dealer channels,” said Michael D. Heil, President and Chief Executive Officer of iGo, Inc. “With their global reach into more than 50 countries and 80,000 points of sale, Brightstar is becoming a major force in the mobile accessories category.”

About iGo, Inc.

iGo, Inc. offers a full line of innovative accessories for almost every mobile electronic device on the market. Whether a consumer wants to power, protect, listen to, share, cool, hold or connect to their device, iGo has the accessories they need. iGo is also a leader in developing eco-friendly power solutions based on its patented iGo Green® technology, which automatically reduces the wasteful and expensive standby, or “vampire,” power consumed by electronic devices.

iGo’s products are available at www.iGo.com as well as through leading resellers and retailers. For additional information call 480-596-0061, or visit www.igo.com.

iGo is a registered trademark of iGo, Inc. All other trademarks or registered trademarks are the property of their respective owners.

This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. The words “believe,” “expect,” “anticipate,” “should,” and other similar statements of our expectation identify forward-looking statements. Forward-looking statements in this press release include the Company’s expectation that the distribution agreement with Brightstar can help increase sales globally into operator, retailer and dealer channels. These forward-looking statements are based largely on management’s expectations and involve known and unknown risks, uncertainties and other factors, which may cause the Company’s actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Risks that could cause results to differ materially from those expressed in these forward-looking statements include, among others, our ability to expand and diversify our customer base; increased focus of consumer electronics retailers on their own private label brands; our ability to expand our revenue base and develop new products and product enhancements; fluctuations in our operating results because of: increases in product costs from our suppliers, our suppliers’ ability to perform, the timing of new product and technology introductions and product enhancements relative to our competitors, market acceptance of our products, the size and timing of customer orders, our ability to effectively manage inventory levels, delay or failure to fulfill orders for our products on a timely basis, distribution of or changes in our revenue among distribution partners and retailers, our inability to accurately forecast our contract manufacturing needs, difficulties with new product production implementation or supply chain, product defects and other product quality problems, the degree and rate of growth in our markets and the accompanying demand for our products, our ability to expand our internal and external sales forces and build the required infrastructure to meet anticipated growth, and seasonality of sales; our ability to manage our inventory levels; decreasing sales prices on our products over their sales cycles; our failure to integrate acquired businesses, products and technologies; our reliance on and the risk relating to outsourced manufacturing fulfillment of our products, including potential increases in manufacturing costs; the negative impacts of product returns; design and performance issues with our products; liability claims; our failure to expand or protect our proprietary rights and intellectual property; intellectual property infringement claims against us; our ability to hire and retain qualified personnel; our ability to secure additional financing to meet our future capital needs; increased competition and/or reduced demand in our industry; our failure to comply with domestic and international laws and regulations; economic conditions, political events, war, terrorism, public health issues, natural disasters and similar circumstances; that our common stock could be delisted from the NASDAQ Global Market; volatility in our stock price; concentration of stock ownership among our executive officers and principal stockholders; provisions in our certificate of incorporation, bylaws and Delaware law, as well as our stockholder rights plan, that could make a proposed acquisition of the Company more difficult; and dilution resulting from potential future stock issuances.

Additionally, other factors that could cause actual results to differ materially from those set forth in, contemplated by, or underlying these forward-looking statements are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011 under the heading “Risk Factors.” In light of these risks and uncertainties, the forward-looking statements contained in this press release may not prove to be accurate. The Company undertakes no obligation to publicly update or revise any forward-looking statements, or any facts, events, or circumstances after the date hereof that may bear upon forward-looking statements. Additionally, the Company does not undertake any responsibility to update you on the occurrence of unanticipated events which may cause actual results to differ from those expressed or implied by these forward-looking statements.

CONTACT: Tony Rossi
         Financial Profiles
         310-478-2700 x13
         trossi@finprofiles.com

Securities Lawyers Seek to Improve Shareholder Value at THQ (THQI)

DALLAS, July 9, 2012 /PRNewswire/ — Goldfarb LLP is investigating whether the board of directors of THQ, Inc. (NASDAQ: THQI) violated shareholder protection laws by issuing materially false and misleading statements to investors that artificially inflated the company’s stock price. Concerned THQI investors who held shares before February 3, 2011 are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbllp.com about their rights and remedies.

“The company is accused of issuing false and misleading statements regarding the company’s uDraw GameTablet and its lack of appeal to Microsoft Xbox 360 and Sony PlayStation 3 owners,” securities lawyer Hamilton Lindley said. “Our proposed shareholder lawsuit will seek to ensure that proper controls are placed to correct any improper behavior, and to improve the company’s value for investors.”

Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. THQ, Inc. shareholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@goldfarbllp.com or 877-583-2855.

Hamilton Lindley
Goldfarb LLP
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
hlindley@goldfarbllp.com
www.goldfarbllp.com

GlobalWise (GWIV) ECM Software Intellivue™ Named #1 at Prestigious Managed Printer Conference

COLUMBUS, OH — (Marketwire) — 07/09/12 — GlobalWise Investments, Inc. (OTCBB: GWIV) (OTCQB: GWIV) (the “Company”) (www.GlobalWiseInvestments.com) and its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today announce the Company’s Intellivue™ ECM software was named the number one ECM solution at the recent Global Transform 2012 conference by “The Week in Imaging.”

“The Week in Imaging” (www.theweekinimaging.com) is an online, interactive one-stop news and information source that targets anyone who sells imaging solutions, including independent dealers, VARs, sales and service personnel in manufacturer direct branches as well as hardware manufacturers and solutions and service providers. Global Transform 2012 is a managed print service (MPS) industry conference for providers, partners and IT decision makers in the copier and printer industry.

The online article (www.theweekinimaging.com/author/theweek/page/8/) posted by Art Post on the “The Week in Imaging” Web page and titled “Top 7 Solutions at Photizo’s Transform Conference: Intellivue Cost-Per-Page Billing for Document Management Services @ #1” provides a great overview of the Intellivue™ cloud based document management software and how it can create a new revenue model for the copier and printer dealer industry. The number one ranking by such a prestigious industry resource is a great validator of the power of a cloud delivered software from GlobalWise.

“I am very proud of our team and how well received the Intellivue™ software was at the Transform Conference,” commented William J. “BJ” Santiago, CEO of GlobalWise. “We shared a booth with MWA Intelligence, a new GlobalWise Channel Partner recently announced, and to be recognized as the #1 solution at the show by our industry peers at ‘The Week in Imaging’ is a fantastic win. Copier and printer dealers traditionally derive their income from leasing of hardware and charging for every page printed. Scanning and retrieval of documents was done at no cost to the client, but with little functionality. By integrating the Intellivue™ software into the imaging hardware, copier dealers can instantly expand their service portfolio with an additional value-added offering, creating a new revenue stream.”

“The power of this solution is that there is no upfront cost,” author Art Post stated in the recently published article. “I see Intellivue™ as a tremendous value for the SMB customer. For too long the SMB customer has shied away from content management due to the upfront cost, the training, the IT infrastructure and the thought that they would have to dedicate an employee to operate the software. With this SaaS solution, a company can realize an immediate return on investment from the first month Intellivue™ is deployed.”

About GlobalWise Investments, Inc.

GlobalWise Investments, Inc., via its wholly owned subsidiary Intellinetics, Inc., is a Columbus, Ohio based Enterprise Content Management (ECM) pioneer with industry-leading software that delivers cloud ECM based solutions on-demand. The Company’s flagship platform, Intellivue™, represents a new industry benchmark and game-changing solution by enabling clients to access and manage the content of every scanned document, file, spreadsheet, email, photo, audio file or video tape — virtually anything that can be digitized — in their enterprise from any PC, laptop, tablet or smartphone from anywhere in the world.

For additional information, please visit the Company’s corporate website: www.GlobalWiseInvestments.com

This press release may contain “forward-looking statements.” Expressions of future goals and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements may include, without limitation, statements about our market opportunity, strategies, competition, expected activities and expenditures as we pursue our business plan. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot predict the effect that market conditions, customer acceptance of products, regulatory issues, competitive factors, or other business circumstances and factors described in our filings with the Securities and Exchange Commission may have on our results. The company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.

GlobalWise Investments, Inc.
Columbus, Ohio
www.GlobalWiseInvestments.com
614-388-8909
Contact@GlobalWiseInvestments.com

Mission Investor Relations
Atlanta, Georgia
http://www.MissionIR.com
404-941-8975

Shareholders of Exceed Company Ltd. (EDS) Approve All Board Proposals

Silver Bull (SVBL) Files Updated NI43-101 Report for Sierra Mojada Project

TPI (TPI) Provides Further Updates on its GMOL Flagship Product

AVI BioPharma (AVII) to Present Company Overview

BOTHELL, WA — (Marketwire) — 07/06/12 — AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, announced today that it is scheduled to present at the Seventh Annual JMP Securities Healthcare Conference in New York, NY on Thursday, July 12, at 1:30 p.m. Eastern Time. Chris Garabedian, AVI’s President and CEO, will be the presenter.

The presentation will be webcast live under the events section of AVI’s website at www.avibio.com and will be archived there following the presentation for 90 days. Please connect to AVI’s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About AVI BioPharma
AVI BioPharma is focused on the discovery and development of novel RNA-based therapeutics for rare and infectious diseases, as well as other select disease targets. Applying pioneering technologies developed and optimized by AVI, the Company is able to target a broad range of diseases and disorders through distinct RNA-based mechanisms of action. Unlike other RNA-based approaches, AVI’s technologies can be used to directly target both messenger RNA (mRNA) and precursor messenger RNA (pre-mRNA) to either down-regulate (inhibit) or up-regulate (promote) the expression of targeted genes or proteins. By leveraging its highly differentiated RNA-based technology platform, AVI has built a pipeline of potentially transformative therapeutic agents, including eteplirsen, which is in clinical development for the treatment of Duchenne muscular dystrophy, and multiple drug candidates that are in clinical development for the treatment of infectious disease. For more information, please visit www.avibio.com.

AVI Media and Investor Contact:
Erin Cox
425.354.5140
Email Contact

Cameco and Denison Mines (DNN) on the Upswing as Japan Restarts Two Nuclear Reactors

NEW YORK, NY — (Marketwire) — 07/06/12 — Uranium stocks have been on the upswing recently as Japan has restarted their first nuclear reactor since the Fukushima disaster. The Global X Uranium ETF (URA) — the first ETF to track companies involved in uranium mining — has rebounded over 12 percent in the last month. Five Star Equities examines the outlook for companies in the Uranium Industry and provides equity research on Cameco Corporation (NYSE: CCJ) (TSX: CCO) and Denison Mines Corp. (NYSE: DNN) (TSX: DML).

Access to the full company reports can be found at:

www.FiveStarEquities.com/CCJ

www.FiveStarEquities.com/DNN

Uranium stocks were hit hard in 2011 after a Japanese earthquake and tsunami triggered the worst atomic disaster in 25 years. Following the incident Japan shutdown all 50 of their nuclear reactors, which were responsible for approximately 30 percent of the nation’s electricity. Last week the Japanese government approved to restart the No. 3 and No.4 Ohi units in western Japan.

The “restart of the Japan reactors is likely to be the triggering event to start an upward movement in uranium prices and uranium stocks,” said Steve Laflin, president and CEO of International Isotopes.

Five Star Equities releases regular market updates on the Uranium Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports and industry newsletters.

Cameco is one of the world’s largest uranium producers accounting for about 16% of the world’s production from its mines in Canada and the US. Their leading position is backed by about 435 million pounds of proven and probable reserves and extensive resources. Shares of the company have rebounded nearly 18 percent in the last month.

Denison Mines is a uranium exploration and development company with interests in exploration and development projects in Saskatchewan, Zambia and Mongolia. As well, Denison has a 22.5% ownership interest in the McClean Lake uranium mill, located in northern Saskatchewan, which is one of the world’s largest uranium processing facilities.

Five Star Equities provides Market Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. Five Star Equities has not been compensated by any of the above-mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at:

www.FiveStarEquities.com/disclaimer

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Five Star Equities

TAT Technologies (TATT) 30%-Owned Subsidiary Secures $3 M Loan From Controlling Stockholder

USA Water Polo Teams Up With Jamba Juice (JMBA) to Fight Childhood Obesity

Jamba Donates Water Polo Balls to Local Schools and Partakes in Water Polo Clinic as Part of U.S. Olympic Water Polo Team Send-Off Event

Peregrine (PPHM) to Present at JMP Securities Healthcare Conference

TUSTIN, CA — (Marketwire) — 07/05/12 — Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment and diagnosis of cancer and infectious diseases, today announced that Steven King, president and chief executive officer, will present at the 2012 JMP Securities Healthcare Conference at the Peninsula Hotel in New York, NY on Thursday, July 12, 2012 at 9:30 AM Eastern Daylight Time.

Peregrine’s presentation will be webcast live and available for replay until July 26, 2012 at: http://ir.peregrineinc.com/events.cfm

For more information about this conference, please visit: http://www.jmpg.com/jmpsecurities/about/conferences/

About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing multiple clinical programs in cancer and infectious diseases with its lead product candidate bavituximab and novel brain cancer agent Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.

Contact:
Christopher Keenan or Jay Carlson
Peregrine Pharmaceuticals
(800) 987-8256

ENGlobal (ENG) Awarded Government Defense Contract

Multi-year Contract Renews Existing Long-term Relationship

Houston, July 5, 2012 (GLOBE NEWSWIRE) — ENGlobal (NASDAQ: ENG), a leading provider of energy-related project delivery solutions, today announced that it is one of three firms that has been awarded a multiple award contract for the procurement of automated fuel handling equipment (AFHE) support services to the U.S. Military. If all options are exercised by the United States Navy, the cumulative value of these fixed-price contracts for the three firms is an estimated $215 million and, in that case, work could continue until June 2017.

ENGlobal is one of three firms awarded an indefinite-delivery/indefinite-quantity (ID/IQ), cost-plus-fixed-fee contract for technical and maintenance services for automated tank gauging and automated fuel service stations. The scope of the project includes development, design, engineering, fabrication, integration, installation, quality assurance, logistics, maintenance, life-cycle management and technical support for AFHE systems. Work will be performed at Department of Defense fuel facilities worldwide, and is expected to be completed by the second quarter 2013.

Space and Naval Warfare (SPAWAR) Systems Center Atlantic, in Charleston, South Carolina provides contracting activity administration services on behalf of multiple Department of Defense military departments. The U.S. Department of Defense announced this Navy contract award on June 14, 2012: http://www.defense.gov/contracts/contract.aspx?contractid=4812

“ENGlobal has a proven track record of delivering exceptional service to SPAWAR since 2007,” said Edward L. Pagano, ENGlobal’s President and Chief Executive Officer. “This cumulative award for the three firms represents an increase of approximately $89 million over the 2007 award level of $126 million and, as validated by our performance, we will make every effort to increase ENGlobal’s portion of the base contract funding.”

Mr. Pagano continued. “Our Government Services division, based in Tulsa, Oklahoma, specializes in the turn-key installation and maintenance of automation and instrumentation systems for the U.S. defense industry worldwide. This award demonstrates that our technical capability for AFHE engineering support extends globally to keep Department of Defense fuel systems fully mission capable.”

About Space and Naval Warfare (SPAWAR) Systems Center, Charleston
Space and Naval Warfare (SPAWAR) Systems Center, Charleston provides advanced communications and information capabilities across Department of the Navy, joint and coalition forces and consists of more than 12,000 highly-dedicated employees and contractors, deployed globally and near the fleet. Please visit www.public.navy.mil/spawar for more information.

About ENGlobal
ENGlobal (NASDAQ: ENG), founded in 1985, is a provider of engineering and related project services principally to the energy sector throughout the United States and internationally. ENGlobal operates through three business segments: Automation, Engineering & Construction, and Field Solutions. ENGlobal’s Automation segment provides services related to the design, fabrication & implementation of process distributed control and analyzer systems, advanced automation, and related information technology. The Engineering & Construction segment provides consulting services relating to the development, management and execution of projects requiring professional engineering as well as inspection, construction management, mechanical integrity, field support, quality assurance and plant asset management. ENGlobal’s Field Solutions segment provides project management and staffing for right-of-way and site acquisition, inspection, permitting, regulatory, and legislative outreach. ENGlobal has approximately 2,000 employees in 11 offices and 9 cities. Further information about the Company and its businesses is available at www.ENGlobal.com.

Safe Harbor for Forward-Looking Statements
The statements above regarding the Company’s expectations regarding its operations and certain other matters discussed in this press release may constitute forward-looking statements within the meaning of the federal securities laws and are subject to risks and uncertainties including, but not limited to: (1) our ability to perform under these contracts, obtain new contracts or modify existing contracts with the U.S. government; (2) our ability to achieve profitability and positive cash flow from operations; (3) our ability to collect accounts receivable and process accounts payable in a timely manner; (4) our ability to comply with the terms of our credit facility with PNC and our existing letter of credit facility with Export-Import Bank of the United States; (5) our ability to respond appropriately to the current worldwide economic situation and the resulting decrease in demand for our services and competitive pricing pressure; (6) our ability to achieve our business strategy while effectively managing costs and expenses; (7) our ability to accurately estimate costs and fees on fixed-price contracts; (8) the effect of changes in the price of oil; (9) delays related to the award of domestic and international contracts; (10) our ability to execute to our internal performance plans such as our productivity improvement and cost reduction initiatives; (11) the effect of changes in laws and regulations with which the Company must comply and the associated costs of compliance with such laws and regulations, either currently or in the future, as applicable; (12) the effect of changes in accounting policies and practices as may be adopted by regulatory agencies, as well as by the FASB; (13) the effect on our competitive position within our market area in view of, among other things, increasing consolidation currently taking place among our competitors; (14) our ability to win new business and convert those orders to sales within the fiscal year in accordance with our annual business plan; (15) achievement of our acquisition and related integration plans; and (16) the uncertainties of the outcome of litigation. Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in ENGlobal’s filings with the Securities and Exchange Commission. In addition, reference is hereby made to cautionary statements set forth in the Company’s most recent reports on Form 10-K and 10-Q, and other SEC filings.

Click here to join our email list: http://www.b2i.us/irpass.asp?BzID=702&to=ea&s=0.

###

CONTACT: Natalie Hairston
         281-878-1000
         ir@englobal.com

Asure Software (ASUR) Announces Acquisition of PeopleCube

Acquisition Solidifies Asure’s Portfolio and Position as Leading Global Provider of Workspace and Workforce Management Solutions

• Expects Q2 2012 results (pre-acquisition) to be at upper end of revenue and EBITDA (ex one-time items) guidance
• Increases Q3 and Q4 2012 revenue guidance to $6.9 M – $7.1M and $7.8M – $8.1M, respectively (primarily as a result of the acquisition)
• Increases Q3 and Q4 EBITDA guidance (ex one-time items) to $1.1M – $1.3M and $1.9M – $2.2M, respectively (primarily as a result of the acquisition)
• Issues 2013 guidance of $31M revenue, $9M EBITDA, and $7M ($1.30 per share) of free cash flow

AUSTIN, Texas, July 5, 2012 (GLOBE NEWSWIRE) — Asure Software, Inc. (Nasdaq:ASUR), a leading provider of workplace management software, today announced that it has acquired PeopleCube, of Framingham, MA. PeopleCube has enabled the deployment of a high-quality, flexible workplace and the ability to plan, schedule, measure and analyze space and resource utilization to attain new levels of effectiveness and efficiency. One of the leaders in providing intelligent on-demand workplace management solutions that help customers manage their facilities, PeopleCube solutions minimize real estate, meeting services, travel, and energy costs based on actual workspace usage. PeopleCube supports 7,500 Clients in small, medium, and large enterprises around the world. With this acquisition, Asure becomes the leading global provider of workspace management solutions.

On July 3, 2012, Asure Software entered into a stock purchase agreement to acquire PeopleCube for a combination of cash and stock. The purchase price was composed of $9.8 million cash paid at closing; a $3 million, two-year seller’s note; and the issuance of 255,000 shares of common stock, representing just under five percent of Asure’s outstanding shares. Asure financed the deal via a new debt financing facility with further details of the acquisition and financing facility to be detailed in Asure’s 8K (to be filed shortly). In addition to funding the acquisition, the new facility allowed Asure to re-finance certain of its existing debt.

“PeopleCube’s product suite of workplace management solutions helps companies improve efficiencies in workplaces every day, and is directly in line with the Asure Software strategy,” said Pat Goepel, Asure’s Chief Executive Officer. “We are excited to integrate best practices of the PeopleCube product line to the Asure solution set. The enterprise service model will greatly improve our ability to bring solutions to companies of all sizes in a much larger marketplace.”

“This acquisition creates a global leader in providing solutions that manage workspace environments,” said John Anderson, former President and Chief Executive Officer of PeopleCube who will remain at the company. “The overall suite of available products and services extends Asure’s reach to the workspace management needs of organizations around the world.” PeopleCube’s Resource Scheduler, Workspace Manager, PeopleCounter, Workplace Business Intelligence, and Energy Management solutions will be carried forward and will be incorporated into the newly formed AsureSpace business line which will be led by Anderson.

“The financial synergies from the acquisition are readily identifiable and implementation is already underway,” said Asure’s Chief Financial Officer, David Scoglio. “Efficiencies will come in the form of savings through consolidation, streamlining of deployment and adoption activities, reducing duplicative costs, and leveraging our hosting infrastructure across the larger company. We expect the PeopleCube acquisition to increase the cash generation of the business, and we anticipate realizing significant synergies in the near-term.”

“Given the product and business synergies between PeopleCube and Asure Software, this acquisition is a win-win for clients of both organizations,” added Steven Rodriguez, Chief Operating Officer for Asure. “We have the ability to enhance our customer offering in existing verticals while expanding into additional key vertical markets ranging from small business to enterprise clients on a global scale. No other company has the ability to serve that market potential. Our value proposition is powerful, and we are excited to push our new capabilities to our clients now exceeding over 11,000 combined.”

“We have rebuilt Asure into a larger, more agile company with a predictable recurring revenue stream and strong organic cloud bookings growth, with high incremental margins on that growth,” added Mr. Goepel. “The integration of PeopleCube completely fits into this strategy. We have tripled the size of our company in the past three years, and this acquisition will further improve our ability to deliver significant new bookings growth. We believe we are on the right path to enhancing shareholder value, and hope to report further progress as we move forward.”

About Asure Software

Asure Software, Inc. (Nasdaq:ASUR), headquartered in Austin, Texas, offers intuitive and innovative technologies that enable companies of all sizes and complexities to operate more efficiently. The company ensures a high-performing work environment by integrating its “keep it simple” solutions and expertise to more than 3,500 clients worldwide. Asure Software’s suite of solutions range from time and attendance workforce management solutions to asset optimization and meeting room management. For more information, please visit www.asuresoftware.com.

The Asure Software, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=11986

About PeopleCube

PeopleCube provides intelligent on-demand workplace management solutions that help customers cut real estate, meeting services, travel, and energy costs based on actual workspace usage. Through its corporate headquarters in Framingham, Massachusetts, and offices around the world, PeopleCube supports 8,000 Clients and more than 2.7 million users in small, medium, and large enterprises around the world. More information is available at www.peoplecube.com.

CONTACT: David Scoglio, CFO
         Asure Software, Inc.
         512-437-2732
         dscoglio@asuresoftware.com

         Jon Cunningham
         RedChip Companies, Inc.
         Tel: +1-800-733-2447, Ext. 107
         info@redchip.com
         http://www.redchip.com

Premier Exhibitions (PRXI) Announces Executive Leadership Appointments

ATLANTA, July 3, 2012 (GLOBE NEWSWIRE) — Premier Exhibitions, Inc., (“Premier” or the “Company”), (Nasdaq:PRXI), a leading presenter of museum-quality touring exhibitions around the world, today announced two changes to its executive leadership team.

The following changes are effective immediately:

• Samuel Weiser, who has served as Interim President and Chief Executive Officer since November 2011, will assume the permanent position of President and Chief Executive Officer. Mr. Weiser will continue to manage Premier’s overall business operations, with a specific focus on Premier Exhibition Management, the Company’s exhibition production division. Mr. Weiser is currently a director of the Company and will continue to hold that position.
• John Norman, who has served as the President of the Arts and Exhibitions International division of AEG Live, until its April 2012 acquisition by the Company, will assume the title of President of Arts and Exhibitions International, LLC, a subsidiary of Premier Exhibition Management, LLC (“PEM”), which is a subsidiary of the Company.

Mark Sellers, Premier’s Chairman, stated, “The Board of Directors is pleased to announce these appointments. As we move towards the sale of our Titanic assets, we continue to focus on enhancing our market profile as the recognized leader in developing and displaying unique exhibitions for education and entertainment. Our board believes Sam Weiser’s experience and leadership make him the right person to further our industry leadership and maximize revenue and shareholder return from our exhibition business.”

Sam Weiser, Premier’s President and CEO added, “The addition of John Norman adds a recognized industry leader who has unique access to content and creative development opportunities to the Company’s management team. John’s relationships within the museum community and with content providers around the world position Premier to move forward and grow following the sale of our Titanic assets. Through PEM’s Arts and Exhibitions subsidiary, we anticipate John and his team will develop and tour new and provocative exhibitions rivaling AEI’s current portfolio that includes King Tut, Cleopatra, Real Pirates and America I Am.”

About Premier Exhibitions

Premier Exhibitions, Inc. (Nasdaq:PRXI), located in Atlanta, GA, is a major provider of museum-quality exhibitions throughout the world and a recognized leader in developing and displaying unique exhibitions for education and entertainment. The Company’s exhibitions present unique opportunities to experience compelling stories using authentic objects and artifacts in diverse environments. Exhibitions are presented in museums, exhibition centers and other entertainment venues.

Additional information about Premier Exhibitions, Inc. is available at www.prxi.com.

The Premier Exhibitions, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12992

CONTACT: Investor Contact:
         Michael J. Little
         Chief Financial Officer and Chief Operating Officer
         (404) 842-2600
         michael.little@prxi.com

This Independence Day, Autobytel (ABTL) Salutes American Cars

Autobytel Lists Consumer Favorites, All Made in the USA

Families across the nation will be gathered together to celebrate our great country on July 4^th. Autobytel^® editors also celebrate America by highlighting the best of American automotive manufacturing.

According to Michelle Naranjo, editor-in-chief, Autobytel.com, “2012 is seeing a resurgence in American manufacturing: both for American brands and the collection of Japanese, German and Korean automakers who have built manufacturing plants on American soil and employ American citizens.” She continued, “the label ‘Made in America’ is something to be proud of. Whether it’s a foreign car made in America, or a traditional American manufacturer, American workers can equal or better their counterparts in the rest of the world.”

While the American automotive industry saw some pretty bleak times a few years ago, the recent comeback in sales is just an indicator of improvements that came in leaps and bounds in design, manufacturing, technology and fuel-economy sectors of automotive manufacturing.

This year, to celebrate the 4^th of July, Autobytel editors share the Autobytel and AutoPacific lists of the cars that are made in America and have the best ratings from actual owners in their respective categories. More than 75,000 new car buyers who were within their first three months of ownership were surveyed. Autobytel editors have taken those consumer ratings and compiled lists of some of the most satisfying cars that are made in America, by American brands and by foreign car companies.

The top seven great American cars among the top-rated models revealed by Autobytel editors include: Top-Rated Luxury SUV: Cadillac Escalade; Top-Rated Sports Car: Chevrolet Corvette; Top-Rated Economy Car: Chevrolet Sonic; Top-Rated Crossover Utility Vehicle: Chevrolet Traverse; Top-Rated Light Duty Pickup Truck: Ford F-150; Top-Rated Large Sports Utility Vehicle: GMC Yukon; Top-Rated Mid-Sized Sports Utility Vehicle: Jeep Grand Cherokee.

Autobytel editors also feature the seven most satisfying foreign cars made in America. These include: Top-Rated Mid-Size Crossover SUV: Honda CR-V; Top-Rated Minivan: Honda Odyssey; Top-Rated Premium Mid-Size Crossover SUV: Honda Pilot; Top-Rated Hybrid Car: Hyundai Sonata Hybrid; Top-Rated Premium Luxury Crossover SUV: Mercedes-Benz-M Class; Top-Rated Mid-Size Car: Subaru Legacy.

For more information on the favorite American cars, visit at www.Autobytel.com. Also visit the site for more insights from the editors. Watch exclusive videos on Autobytel’s YouTube page or join the conversation on the Autobytel Facebook Fan Page.

About Autobytel Inc.
Autobytel Inc., an online leader offering consumer purchase requests and marketing resources to car dealers and manufacturers and providing consumers with the information they need to purchase new and used cars, pioneered the automotive Internet when it launched its flagship website in 1995. Autobytel continues to offer innovative products and services to help consumers buy, and auto dealers and manufacturers sell, more used and new cars. Autobytel has helped tens of millions of automotive consumers research vehicles; connected thousands of dealers nationwide with motivated car buyers; and helped every major automaker market its brand online. Through its flagship website, network of automotive sites and respected online affiliates, Autobytel continues its dedication to innovating the industry’s highest quality Internet programs to provide consumers with a comprehensive and positive automotive research and purchasing experience, and auto dealers, dealer groups and auto manufacturers with some of the industry’s most productive and cost-effective customer referral and marketing programs.

Investors and other interested parties can receive Autobytel news releases and invitations to special events by accessing our online signup form at http://investor.autobytel.com/alerts.cfm

TeleCommunication Systems (TSYS) Debuts in Washington Technology’s 2012 Top 100

Avalon (AVL) Buys Out Thor Lake NSR Royalty

TORONTO, ONTARIO — (Marketwire) — 07/03/12 — Avalon Rare Metals Inc. (TSX:AVL)(NYSE MKT:AVL) (“Avalon” or the “Company”) is pleased to announce that it has bought out the 3% Calabras/Lutoda Net Smelter Return (“NSR”) royalty on its Thor Lake property for a cash payment of CAD$2.0 million. The Thor Lake property (the “Property”) encompasses the Company’s flagship Nechalacho Rare Earth Elements Deposit.

The 3% Calabras/Lutoda NSR was one of two NSR royalties on the Property that the Company inherited when it acquired title to the Property in 2005. Avalon has the contractual right to buy out the remaining 2.5% royalty on the basis of a fixed formula, which currently approximates CAD$1.3 million and which will increase at a rate equal to the Canadian prime rate until that royalty is also bought out.

Don Bubar, Avalon’s President and CEO commented, “Acquiring this royalty interest is an important step in the development of our Nechalacho Deposit. Our ability to move this project forward without the uncertainty of a royalty burden has long been part of our development model and we are pleased that we were able to conclude this agreement with the royalty holders on favourable terms.”

About Avalon Rare Metals Inc.

Avalon Rare Metals Inc. (TSX:AVL)(NYSE MKT:AVL) is a mineral development company focused on rare metals deposits in Canada. Its flagship project, the 100%-owned Nechalacho Deposit, Thor Lake, NWT, is emerging as one of the largest undeveloped rare earth elements resources in the world. Its exceptional enrichment in the more valuable ‘heavy’ rare earth elements, which are key to enabling advances in green energy technology and other growing high-tech applications, is one of the few potential sources of these critical elements outside of China, currently the source of 95% of world supply. Avalon is well funded, has no debt and its work programs are progressing steadily. Social responsibility and environmental stewardship are corporate cornerstones.

Shares Outstanding: 103,611,986. Cash resources: approximately $41 million.

To find out more about Avalon Rare Metals Inc., please visit our website at www.avalonraremetals.com.

This news release contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Generally, these forward-looking statements can be identified by the use of forward looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Avalon to be materially different from those expressed or implied by such forward-looking statements. Forward-looking statements are based on assumptions management believes to be reasonable at the time such statements are made. Although Avalon has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Such forward-looking statements have been provided for the purpose of assisting investors in understanding the Company’s plans may not be appropriate for other purposes. Accordingly, readers should not place undue reliance on forward-looking statements. Avalon does not undertake to update any forward-looking statements that are contained herein, except in accordance with applicable securities laws.

Contacts:
Avalon Rare Metals Inc.
Don Bubar
President
416-364-4938
ir@avalonraremetals.com

RADCOM (RDCM) to Publish Q2 Results on Tuesday July 24th, 2012

Platinum Group (PLG) Confirms Plans

VANCOUVER, BRITISH COLUMBIA and JOHANNESBURG, SOUTH AFRICA — (Marketwire) — 06/19/12 — Platinum Group Metals Ltd. (TSX:PTM)(NYSE MKT:PLG)(NYSE Amex:PLG) (“Platinum Group” or the “Company”), confirms that, in line with previous guidance, it is proceeding with its plans to finance and complete the WBJV Project 1 Platinum Mine as well as explore and expand its new Waterberg discovery, in South Africa.

R. Michael Jones said, “We have a high grade competitive platinum deposit at WBJV Project 1 and the construction and banking plans for project finance are progressing well. The WBJV Project 1 mine is near surface and has excellent grade. The competitive nature of this project is highlighted at this time of increasing costs and mine closures. At Waterberg, we have extraordinary grade thickness, located near surface and eight drill rigs continue to expand this new discovery. We have solid confidence in the platinum market in the medium and long term and confidence of our position in that market as we drive towards first production in mid 2014.”

Phase 1 at the WBJV Project 1 Platinum Mine (74% Platinum Group and 26% JSE listed Wesizwe Platinum) was budgeted at USD $100 million for acquisition of surface rights, completion of declines into the ore body and construction of surface infrastructure. This work is funded, now over half way complete and on budget. A full Mining Right for the project was granted by the Government of South Africa on April 4, 2012.

The final steps for the completion of project finance banking and the execution of off-take arrangements with a smelter are expected in the weeks ahead, materially in-line with previous guidance.

During the last few months Platinum Group has made solid progress on construction at the WBJV Project 1 Platinum Mine. Sinking of the twin central declines is progressing safely and efficiently. The declines are at approximately 300 metres of linear sinking, complete with cross cuts, ventilation and muck bays. Although the declines are a few weeks behind in planned linear completion to date, the teams are improving the rate of face advance weekly for a projected on time completion. Phase 1 surface infrastructure is now essentially complete. Construction of Eskom substations and design work for water connections in preparation for Phase 2 are underway, within the Phase 1 budget, as a result savings and efficiencies to date. Also as a result of savings on the Phase 1 program, the construction of a second, southern twin decline access into the ore body is underway. This work is now progressing very well and is ahead of schedule. This second twin decline access is a critical path item in preparation for Phase 2, which will include milling, processing and tailings facilities.

At the Company’s exciting Waterberg Project on the North Limb of the Bushveld Complex, the newly discovered multiple layers of thick mineralization continue to be intersected in step out holes along strike, up dip and down dip. The zones remain open for expansion in all directions. Eight rigs are currently at work at Waterberg on a 250 meter by 250 meter grid with some larger scale step outs also in progress up to 1.0 km further along strike. An expanded budget for 2012 exploration is currently working through the approval process amongst the parties to the joint venture. An initial resource estimate at Waterberg is planned in the near term.

The Waterberg project is 49.9% owned by Platinum Group while Japanese state exploration company JOGMEC is a 37% joint venture partner. The balance is held by a South African empowerment company.

Qualified Person

The non-Independent Qualified Person for this News Release is R. Michael Jones, P.Eng. He is non-independent, the Company CEO and a significant shareholder. He has relevant supervision experience in South Africa since 2002 and has experience with feasibility studies and supervision of precious metals mine operations. He has verified the data through checking the calculations, checking samples of the core and by visiting with the qualified employees that have completed the work in South Africa. QAQC procedures include blanks, standards and chain of custody processes as previously reported.

About Platinum Group Metals Ltd.

Platinum Group has an experienced mine building and operating team based in Vancouver, Canada and Johannesburg, South Africa. Platinum Group Metals Ltd is building the WBJV Project 1 Platinum mine in the Western Limb of the Bushveld Complex South Africa. The Company owns 74% of the WBJV Project 1 Mine and 26% is owned by Wesizwe which is controlled by Jinchuan of China. Platinum Group is listed as PLG on the NYSE MKT and PTM on the TSX in Toronto.

On behalf of the Board of Platinum Group Metals Ltd.

R. Michael Jones

This press release contains forward-looking information within the meaning of Canadian securities laws and forward-looking statements within the meaning of U.S. securities laws (“forward-looking statements”). Forward-looking statements are typically identified by words such as: believe, expect, anticipate, intend, estimate, plans, postulate and similar expressions, or are those, which, by their nature, refer to future events. All statements that are not statements of historical fact are forward-looking statements. Forward-looking statements in this press release include, without limitation, statements regarding the Company’s plans to move into full scale development in the months ahead, the timing of any debt/financing for Project 1, the completion of account structuring and off-take negotiations in Q2 of calendar 2012, the amount of increase in the peak funding estimate for Project 1, the timing of first ore production and concentrate sales, and further exploration on the Company’s properties. In addition, the results of the UFS and subsequent cost estimate disclosure may constitute forward-looking statements to the extent that they reflect estimates of mineralization, capital and operating expenses, metal prices and other factors. Although the Company believes the forward-looking statements in this press release are reasonable, it can give no assurance that the expectations and assumptions in such statements will prove to be correct. The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking statements as a result of various factors, including, but not limited to, variations in market conditions; the nature, quality and quantity of any mineral deposits that may be locate;, the Company’s ability to obtain any necessary permits, consents or authorizations required for its activities; the Company’s ability to successfully complete hedging establishment and off-take negotiations; the Company’s ability to produce minerals from its properties successfully or profitably, to continue its projected growth, or to be fully able to implement its business strategies and other risk factors described in the Company’s Form 40-F annual report, annual information form and other filings with the SEC and Canadian securities regulators, which may be viewed at www.sec.gov and www.sedar.com , respectively.

The Toronto Stock Exchange and the NYSE MKT LLC have not reviewed and do not accept responsibility for the accuracy or adequacy of this news release, which has been prepared by management.

Contacts:
Platinum Group Metals Ltd.
R. Michael Jones
President
(604) 899-5450 / Toll Free: (866) 899-5450

Platinum Group Metals Ltd.
Kris Begic
Vice President, Corporate Development
(604) 899-5450 / Toll Free: (866) 899-5450
(604) 484-4710 (FAX)

TranS1 Inc. (TSON) Announces CE Mark for VEO™ Minimally Invasive Lateral Fusion System

WILMINGTON, N.C., July 3, 2012 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON), a pioneer in minimally invasive approaches to lumbar spine surgery, today announced it has received CE (Conformité Européenne) Mark approval in the European Union to market its VEO^TM lateral access fusion system for interbody fusions.

Ken Reali, President and Chief Executive Officer of TranS1, stated, “We are very pleased to receive the CE Mark for the VEO lateral system. This approval represents a significant milestone for TranS1 and will contribute to our efforts to become a leader in minimally invasive spine surgery. We are excited to begin executing on our commercialization strategy in Europe as we enter the third quarter.”

The VEO minimally invasive lateral system features an innovative, two-stage retraction method that focuses on nerve visualization and then controlled retraction. The VEO system is designed for direct visualization of the psoas muscles and adjacent nerves prior to muscle dissection.

The VEO retractor is complemented by a full range of PEEK lateral interbody implants and a variety of ergonomic instruments. Radiopaque markers are strategically located within the implants to allow proper placement.

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF® family of products for single and two level lumbar fusion, the VEO lateral access and interbody fusion system, and the Vectre^TM and Avatar^TM posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.

CONTACT: Investors:
         TranS1 Inc.
         Joseph P. Slattery, 910-332-1700
         Executive Vice-President and Chief Financial Officer

         Westwicke Partners
         Mark Klausner, 443-213-0501
         trans1@westwicke.com

Cardiome (CRME) Announces Management Change

Longwei Petroleum (LPH) Announces Completion of Tax Reconciliation Report by Independent Auditors

Independent Auditors Complete Tax Reconciliation of SAT and SAIC Filings Compared to US GAAP Filings; Company Reports No Material Differences

Rexahn (RNN) Submits an Investigational New Drug Application

Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors. RX-5902 is a first-in-class small molecule that inhibits the phosphorylated p68 RNA helicase, a protein that plays a key role in cancer growth, progression and metastasis. The phosphorylated form of p68 RNA helicase is only present in cancer cells and is absent in normal cells.

“RX-5902 is an exciting first-in-class p68 RNA helicase inhibitor that has considerable commercial potential,” said Rick Soni, President of Rexahn. “Pre-clinical studies have shown that RX-5902 exhibits very potent anti-tumor activity in various cancers including melanoma, renal, ovarian and pancreatic. Additional studies suggest that RX-5902 is effective in drug-resistant cancer cells and is synergistic when combined with current cancer drugs.”

About Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals is a clinical stage pharmaceutical company dedicated to developing and commercializing first in class and market leading therapeutics for cancer, CNS disorders, sexual dysfunction and other unmet medical needs. Rexahn currently has three drug candidates in Phase II clinical trials, Archexin®, Serdaxin®, and Zoraxel™ and a robust pipeline of preclinical compounds to treat multiple cancers and CNS disorders. Rexahn also operates key R&D programs of nano-medicines, 3D-GOLD, and TIMES drug discovery platforms. For more information, please visit www.rexahn.com.

Safe Harbor

To the extent any statements made in this press release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about Rexahn’s plans, objectives, expectations and intentions with respect to future operations and products and other statements identified by words such as “will,” “potential,” “could,” “can,” “believe,” “intends,” “continue,” “plans,” “expects,” “anticipates,” “estimates,” “may,” other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause Rexahn’s actual results to be materially different than those expressed in or implied by Rexahn’s forward-looking statements. For Rexahn, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of Rexahn’s licensees or sublicensees; the success of clinical testing; and Rexahn’s need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect Rexahn’s actual results are described in Rexahn’s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. Rexahn undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.